Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Hamann

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
Journal of the American Chemical Society|March 5, 2021
Intermolecular Crossed [2 + 2] Cycloaddition Promoted by Visible-Light Triplet Photosensitization: Expedient Access to Polysubstituted 2-Oxaspiro[3.3]heptanesPhilip R D Murray, Willem M M Bussink, Geraint H M Davies, et al.
Journal of the American Chemical Society|December 28, 2020
Quaternary Charge-Transfer Complex Enables Photoenzymatic Intermolecular Hydroalkylation of OlefinsClaire G Page, Simon J Cooper, Jacob S DeHovitz, et al.
ACS Medicinal Chemistry Letters|January 29, 2016
Potent, Selective, and Orally Bioavailable Inhibitors of VPS34 Provide Chemical Tools to Modulate Autophagy in VivoAyako Honda, Edmund Harrington, Ivan Cornella-Taracido, et al.
Biochimica Et Biophysica Acta|August 21, 2007
Cofactor-specific modulation of 11beta-hydroxysteroid dehydrogenase 1 inhibitor potencyBhavana Sahni-Arya, Michael J Flynn, Laurie Bergeron, et al.
Bioorganic & Medicinal Chemistry|June 7, 2020
Discovery of a novel indole pharmacophore for the irreversible inhibition of myeloperoxidase (MPO)Anup Patnaik, Laura Axford, Lin Deng, et al.
Journal of Medicinal Chemistry|August 6, 2010
Discovery of 6-(aminomethyl)-5-(2,4-dichlorophenyl)-7-methylimidazo[1,2-a]pyrimidine-2-carboxamides as potent, selective dipeptidyl peptidase-4 (DPP4) inhibitorsWei Meng, Robert P Brigance, Hannguang J Chao, et al.
Nature Communications|February 24, 2026
Context-dependent translation inhibition as a cancer therapeutic modalityPaige D Diamond, Paul V Sauer, Mikael Holm, et al.
Journal of Medicinal Chemistry|August 23, 2013
Optimization of activity, selectivity, and liability profiles in 5-oxopyrrolopyridine DPP4 inhibitors leading to clinical candidate (Sa)-2-(3-(aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-5-oxo-5H-pyrrolo[3,4-b]pyridin-6(7H)-yl)-N,N-dimethylacetamide (BMS-767778)Pratik Devasthale, Ying Wang, Wei Wang, et al.
Endocrinology|September 30, 2006
Pharmacological and x-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in ratsJacek Ostrowski, Joyce E Kuhns, John A Lupisella, et al.
Journal of Medicinal Chemistry|March 16, 2017
Discovery of an Acrylic Acid Based Tetrahydroisoquinoline as an Orally Bioavailable Selective Estrogen Receptor Degrader for ERα+ Breast CancerHeather E Burks, Tinya Abrams, Christina A Kirby, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
Journal of the American Chemical Society|March 5, 2021
Intermolecular Crossed [2 + 2] Cycloaddition Promoted by Visible-Light Triplet Photosensitization: Expedient Access to Polysubstituted 2-Oxaspiro[3.3]heptanesPhilip R D Murray, Willem M M Bussink, Geraint H M Davies, et al.
Journal of the American Chemical Society|December 28, 2020
Quaternary Charge-Transfer Complex Enables Photoenzymatic Intermolecular Hydroalkylation of OlefinsClaire G Page, Simon J Cooper, Jacob S DeHovitz, et al.
ACS Medicinal Chemistry Letters|January 29, 2016
Potent, Selective, and Orally Bioavailable Inhibitors of VPS34 Provide Chemical Tools to Modulate Autophagy in VivoAyako Honda, Edmund Harrington, Ivan Cornella-Taracido, et al.
Biochimica Et Biophysica Acta|August 21, 2007
Cofactor-specific modulation of 11beta-hydroxysteroid dehydrogenase 1 inhibitor potencyBhavana Sahni-Arya, Michael J Flynn, Laurie Bergeron, et al.
Bioorganic & Medicinal Chemistry|June 7, 2020
Discovery of a novel indole pharmacophore for the irreversible inhibition of myeloperoxidase (MPO)Anup Patnaik, Laura Axford, Lin Deng, et al.
Journal of Medicinal Chemistry|August 6, 2010
Discovery of 6-(aminomethyl)-5-(2,4-dichlorophenyl)-7-methylimidazo[1,2-a]pyrimidine-2-carboxamides as potent, selective dipeptidyl peptidase-4 (DPP4) inhibitorsWei Meng, Robert P Brigance, Hannguang J Chao, et al.
Nature Communications|February 24, 2026
Context-dependent translation inhibition as a cancer therapeutic modalityPaige D Diamond, Paul V Sauer, Mikael Holm, et al.
Journal of Medicinal Chemistry|August 23, 2013
Optimization of activity, selectivity, and liability profiles in 5-oxopyrrolopyridine DPP4 inhibitors leading to clinical candidate (Sa)-2-(3-(aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl-5-oxo-5H-pyrrolo[3,4-b]pyridin-6(7H)-yl)-N,N-dimethylacetamide (BMS-767778)Pratik Devasthale, Ying Wang, Wei Wang, et al.
Endocrinology|September 30, 2006
Pharmacological and x-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in ratsJacek Ostrowski, Joyce E Kuhns, John A Lupisella, et al.
Journal of Medicinal Chemistry|March 16, 2017
Discovery of an Acrylic Acid Based Tetrahydroisoquinoline as an Orally Bioavailable Selective Estrogen Receptor Degrader for ERα+ Breast CancerHeather E Burks, Tinya Abrams, Christina A Kirby, et al.
Pageof 12